GenVec Inc. (GNVC) Achieves First Milestone in Collaboration, Eligible to Receive up to $213.6 Million on Sales GAITHERSBURG, Md., Sept. 14 /PRNewswire/ -- GenVec, Inc. (Nasdaq: GNVC) today announced ...

The beleaguered gene therapy field hasn't exactly proven a hotbed for dealmaking, and Novartis' (NVS) decision to pony-up a little cash for GenVec's (GNVC) preclinical hearing loss program could be a ...

Ghana New Ventures Competition (GNVC) Officially Launches Summer Internship Engagement as Part of University Connections Programme Accra, Ghana ? Monday, 28 June, 2004 ? Ghana New Ventures Competition ...

GenVec, Inc. (GNVC) has been on the move lately as the stock has risen by 83.5% in the past four weeks, and it is currently trading well above its 20-Day SMA. This is a pretty solid move higher, but ...

The Biotech Industry has continued to provide investors with impressive gains in 2013. The iShares NASDAQ Biotechnology ETF (NASDAQ:IBB - News) and the SPDR S&P Biotech ETF (NYSEARCA:XBI - News) have ...

GenVec (NASDAQ:GNVC) surged in morning trade after announcing a new collaborative deal with animal healthcare company Merial in developing and commercializing technology used to produce foot-and-mouth ...

GAITHERSBURG, Md., June 15, 2010 /PRNewswire via COMTEX/ -- GenVec, Inc. /quotes/comstock/15*!gnvc/quotes/nls/gnvc (GNVC 0.50, -0.01, -1.67%) today announced that it ...

Shares of GenVec (NASDAQ:GNVC) soared 12% Thursday morning after the medicine and vaccine maker said it received a conditional license for a foot-and-mouth disease vaccine for use in cattle. The ...

The Executive MBA branch of Chicago Booth’s top-ranked accelerator program, the Global New Venture Challenge (GNVC), has been characterized by pathbreaking innovation over its twelve year history.